From October 14, 2021 to April 13, 2022, the company has repurchased 251,612 shares, representing 0.89% for KRW 1,997.79 million. With this, the company has completed the repurchase of 251,612 shares, representing 0.89% for KRW 1,997.79 million under the buyback announced on October 14, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,680 KRW | +0.30% | -0.60% | +18.02% |
1st Jan change | Capi. | |
---|---|---|
+18.02% | 132M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- A006620 Stock
- News DongKoo Bio & Pharma Co., Ltd.
- Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on October 14, 2021.